Freshwater: A prospective, multicentre, single-arm feasibility study examining novel treatment delivery of the Evoke Spinal Cord Stimulator (SCS) System to treat patients with chronic pain of the trunk and/or limbs.
Year: 2021
Type: Device
Phase: Post-Market
Indication: Back and/or Leg Pain, Chronic Trunk and/or Limb Pain, Neck / Upper Limb Pain
A 5-year, Randomized, Double-blind, Placebo-controlled, Multi-center Study Assessing the Efficacy, Safety, and Tolerability of Intra-articular Regimens of LNA043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis (ONWARDS).
Year: 2021
Type: Musculoskeletal
Phase: IIb
Indication: Knee Osteoarthritis
Real World Effectiveness of Upadacitinib on Early and Sustained Pain Control in Radiographic Axial Spondyloarthritis (UPSTAND).
Year: 2021
Type: Musculoskeletal
Phase: Post-Market
Indication: Spondyloarthritis
Single-Arm, Multicenter, Study to Evaluate Safety and Efficacy of Ultra-Low Frequency Spinal Cord Stimulator in Subjects with Painful Diabetic Neuropathy.
Year: 2021
Type: Device
Phase: Pre-Market
Indication: Painful Diabetic Neuropathy
A Randomized, Active-Controlled, Parallel Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis.
